TB Online gets a make-over

We have been working hard to give TB Online a face-lift. As a result, you may not see some images, and some features are temporarily not working. But have no fear! The site should be up and fully functioning again shortly. We appreciate your patience and look forward to sharing the new and improved TB Online soon.

Read More →

Will the Ebola epidemic in West Africa impact The Union conference?

While the risk that any conference participant will have Ebola is extremely low, an Ebola preparedness and response plan will be in place throughout the conference. All conference participants will receive information on the preparedness plan when they register or pick up their conference badge.

Read More →

Community Corner at 2014 Union World Conference on Lung Health

The Community Corner is a space for all Union conference attendees to gather, discuss, debate and share ideas on the most pressing issues facing the fight against tuberculosis.

Read More →

TAG symposium: Zero Accountability: when action doesn't match the numbers

2014 International Union Against TB and Lung Disease World Conference
Date: October 30, 2014
Time: 18h00 - 22h00
Location: Hotel Diagonal Zero Barcelona

Read More →

Civil society severely concerned with the Union's scholarship programme for the 45th Union World Conference on Lung Health

Community members, patient advocates and civil society members and representatives from affected communities express their disappointment with the Union's scholarship programme.

Read More →

TB Alliance launches Phase 2B clinical trial of a novel TB drug regimen that could cut treatment time by half or more for a majority of TB patients

NC-005 trial tests a novel regimen of bedaquiline (Sirturo), pretomanid (formerly known as PA-824), and pyrazinamide; results could pave the way for a three-month TB treatment.

Read More →

Short TB regimens fall flat

Two short treatment regimens for tuberculosis failed to match the standard 6 months of therapy in efficacy.

Read More →

Report launch: Falling short

A civil society perspective of the response to multi & extensively drug resistant tuberculosis (M/XDR-TB) in the European region

Read More →

UNITAID Tuberculosis Medicines Technology and Market Landscape (second edition)

The report details current shortcomings in the tuberculosis medicines market and opportunities to improve access to lifesaving TB treatment.

Read More →

WHO: Improved data reveals higher global burden of tuberculosis

WHO’s "Global Tuberculosis Report 2014" shows that 9 million people developed TB in 2013, and 1.5 million died, including 360 000 people who were HIV positive.

Read More →

Page 1 of 46 · Total posts: 10

1 2 Last→

Subscribe to weekly news digest